Merck (MRK) Net Margin (2009 - 2026)

Merck (MRK) has reported Net Margin for 18 consecutive years, with 8.05% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Margin fell 3607.0% year-over-year to 8.05% in Q2 2026; TTM through Jun 2026 was 4.76%, a 2105.0% decrease from a year earlier, with the FY2025 full-year figure at 28.09%, up 139.0% from the prior year.
• Net Margin was 8.05% for Q2 2026 at Merck, up from 26.05% in the prior quarter.
• Over five years, Net Margin peaked at 33.89% in Q2 2024 and troughed at 39.72% in Q2 2023.
• A 5-year average of 15.79% and a median of 22.89% in 2022 frame the typical range for Net Margin.
• Across the five-year window, Net Margin slumped 6678 bps in 2023 and jumped 7361 bps in 2024, its largest moves.
• Over 5 years, Net Margin stood at 21.82% in 2022, then plunged by 138 bps to 8.38% in 2023, then soared by 386 bps to 23.96% in 2024, then retreated by 25 bps to 18.06% in 2025, then slumped by 145 bps to 8.05% in 2026.
• The last three Net Margin figures came in at 8.05% (Q2 2026), 26.05% (Q1 2026), and 18.06% (Q4 2025), per Business Quant data.